Abstract:Inflammatory bowel diseases (IBD) are a multifactorial disorder. Our understanding of the role of bacteria in the pathogenesis of IBD has increased substantially; however, only scarce data exist regarding the role of commensal fungi in maintaining intestinal homeostasis and triggering IBD. Candida albicans (C. albicans) is a member of the intestinal mycobiome and proposed to contribute to IBD pathogenesis. We aimed to investigate the influence of the two morphologies of C. albicans, yeast and hypha, on epithel… Show more
“…Indeed, the expression of MyD88, IRF3, IRF5, and TLR2 was significantly increased in BMECs infected by both the yeast phase and the hypha phase of C. krusei, while the expression of TLR4 was significantly increased by the C. krusei hypha phase. These findings are consistent with previous findings that both the yeast phase and the hypha phase of C. albicans can induce TLR2 and TLR4 upregulation in T cells and human intestinal epithelial cells [56]. It was speculated that both the yeast phase and hypha phase of C. krusei could activate TLR2 in BMECs through the MYD88-dependent signaling pathway, while the activation of TLR4 in BMECs through the MyD88-independent signaling pathway might also be triggered by the hypha phase.…”
Infection with Candida spp. is a significant cause of bovine mastitis globally. We previously found that C. krusei was the main pathogen causing mycotic mastitis in dairy cows in Yinchuan, Ningxia, China. However, whether the infection of this pathogen could induce apoptosis in BMECs remained unclear. In this report, we explored the apoptosis and underlying mechanism of BMECs induced by C. krusei yeast and hypha phases using a pathogen/host cell co-culture model. Our results revealed that both the yeast and hypha phases of C. krusei could induce BMEC apoptosis; however, the yeast phase induced more cell apoptosis than the hypha phase, as assessed via electronic microscopy and flow cytometry assays. This finding was further corroborated via the measurement of the mitochondrial membrane potential (MMP) and the TUNEL test. Infection by both the yeast and hypha phases of C. krusei greatly induced the expression of proteins associated with cell death pathways and important components of toll-like receptor (TLR) signaling, including TLR2 and TLR4 receptors, as determined via a Western blotting assay. BMECs mainly underwent apoptosis after infection by the C. krusei yeast phase through a mitochondrial pathway. Meanwhile, BMEC apoptosis induced by the C. krusei hypha phase was regulated by a death ligand/receptor pathway. In addition, C. krusei-induced BMEC apoptosis was regulated by both the TLR2/ERK and JNK/ERK signaling pathways. These data suggest that the yeast phase and hypha phase of C. krusei induce BMEC apoptosis through distinct cell signaling pathways. This study represents a unique perspective on the molecular processes underlying BMEC apoptosis in response to C. krusei infection.
“…Indeed, the expression of MyD88, IRF3, IRF5, and TLR2 was significantly increased in BMECs infected by both the yeast phase and the hypha phase of C. krusei, while the expression of TLR4 was significantly increased by the C. krusei hypha phase. These findings are consistent with previous findings that both the yeast phase and the hypha phase of C. albicans can induce TLR2 and TLR4 upregulation in T cells and human intestinal epithelial cells [56]. It was speculated that both the yeast phase and hypha phase of C. krusei could activate TLR2 in BMECs through the MYD88-dependent signaling pathway, while the activation of TLR4 in BMECs through the MyD88-independent signaling pathway might also be triggered by the hypha phase.…”
Infection with Candida spp. is a significant cause of bovine mastitis globally. We previously found that C. krusei was the main pathogen causing mycotic mastitis in dairy cows in Yinchuan, Ningxia, China. However, whether the infection of this pathogen could induce apoptosis in BMECs remained unclear. In this report, we explored the apoptosis and underlying mechanism of BMECs induced by C. krusei yeast and hypha phases using a pathogen/host cell co-culture model. Our results revealed that both the yeast and hypha phases of C. krusei could induce BMEC apoptosis; however, the yeast phase induced more cell apoptosis than the hypha phase, as assessed via electronic microscopy and flow cytometry assays. This finding was further corroborated via the measurement of the mitochondrial membrane potential (MMP) and the TUNEL test. Infection by both the yeast and hypha phases of C. krusei greatly induced the expression of proteins associated with cell death pathways and important components of toll-like receptor (TLR) signaling, including TLR2 and TLR4 receptors, as determined via a Western blotting assay. BMECs mainly underwent apoptosis after infection by the C. krusei yeast phase through a mitochondrial pathway. Meanwhile, BMEC apoptosis induced by the C. krusei hypha phase was regulated by a death ligand/receptor pathway. In addition, C. krusei-induced BMEC apoptosis was regulated by both the TLR2/ERK and JNK/ERK signaling pathways. These data suggest that the yeast phase and hypha phase of C. krusei induce BMEC apoptosis through distinct cell signaling pathways. This study represents a unique perspective on the molecular processes underlying BMEC apoptosis in response to C. krusei infection.
“…From an immunological perspective, the in vitro Ca – and EcN–enterocyte interaction models similar to those used in our study have been characterized in the literature. Schirbel et al showed that both yeast and hyphal forms of Ca induce the production of hBD-2 as well as the pro-inflammatory cytokines thymic stromal lymphopoietin, IL-6 and IL-8, in Caco-2 cells [ 36 ]. They also showed increased expression of immune recognition and chemokine receptors, including TLR2, TLR4 and CXCR1 [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…Schirbel et al showed that both yeast and hyphal forms of Ca induce the production of hBD-2 as well as the pro-inflammatory cytokines thymic stromal lymphopoietin, IL-6 and IL-8, in Caco-2 cells [ 36 ]. They also showed increased expression of immune recognition and chemokine receptors, including TLR2, TLR4 and CXCR1 [ 36 ]. Ca was able to activate the NF-κB signaling pathway as well as the cFOS gene, which encodes a subunit of the heterodimeric transcription factor AP-1, reflecting an expected induction of a damage response by the infected enterocytes [ 32 ].…”
Candida albicans is a pathobiont of the gastrointestinal tract. It can contribute to the diversity of the gut microbiome without causing harmful effects. When the immune system is compromised, C. albicans can damage intestinal cells and cause invasive disease. We hypothesize that a therapeutic approach against C. albicans infections can rely on the antimicrobial properties of probiotic bacteria. We investigated the impact of the probiotic strain Escherichia coli Nissle 1917 (EcN) on C. albicans growth and its ability to cause damage to intestinal cells. In co-culture kinetic assays, C. albicans abundance gradually decreased over time compared with C. albicans abundance in the absence of EcN. Quantification of C. albicans survival suggests that EcN exerts a fungicidal activity. Cell-free supernatants (CFS) collected from C. albicans-EcN co-culture mildly altered C. albicans growth, suggesting the involvement of an EcN-released compound. Using a model of co-culture in the presence of human intestinal epithelial cells, we further show that EcN prevents C. albicans from damaging enterocytes both distantly and through direct contact. Consistently, both C. albicans’s filamentous growth and microcolony formation were altered by EcN. Taken together, our study proposes that probiotic-strain EcN can be exploited for future therapeutic approaches against C. albicans infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.